N-Methyl-1-(Trans-4-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Amino)Cyclohexyl)Methanesulfonamide N-甲基-1-(反式-4-(甲基(7H-吡咯并[2,3-d]嘧啶-4-基)氨基)环己基)甲磺酰胺
CAS 1208319-26-9 MFCD308319269
化学结构图
SMILES: CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1
化学属性
| Mol. Weight | 337.44 |
|---|---|
| Appearance | white to off-white solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name Translation | N-甲基-1-(反式-4-(甲基(7H-吡咯并[2,3-d]嘧啶-4-基)氨基)环己基)甲磺酰胺 |
|---|---|
| Chemical Name | N-Methyl-1-(Trans-4-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Amino)Cyclohexyl)Methanesulfonamide |
| PubChem Substance ID | 44631938 |
| InChI | InChI=1S/C15H23N5O2S/c1-16-23(21,22)9-11-3-5-12(6-4-11)20(2)15-13-7-8-17-14(13)18-10-19-15/h7-8,10-12,16H,3-6,9H2,1-2H3,(H,17,18,19)/t11-,12- |
| Synonym | PF03394197; PF-03394197; PF 03394197; Oclacitinib; Apoquel. apoquel oclacitinib |
| Formula | C15H23N5O2S |
| IUPAC Name | N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide |
| InChIKey | HJWLJNBZVZDLAQ-HAQNSBGRSA-N |
| Canonical SMILES | O=S(C[C@H]1CC[C@H](N(C)C2=C3C(NC=C3)=NC=N2)CC1)(NC)=O |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- Oclacitinib, also known as PF03394197, is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 's) ranging from 10 to 99 nM and did not inhibit a panel of 38 non-JAK kinases (IC50 's > 1000 nm). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nm). Oclacitinib also inhibited the function of JAK1-dependent cytokines involved in allergy and inflammation (IL-2, IL-4, IL-6, and IL-13) as well as pruritus (IL-31) at IC50 's ranging from 36 to 249 nM.
